Page 278 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

HKSARG. (2021b). LCQ18: Elderly Health Care Voucher Scheme. https://www.info.gov.hk/gia/
general/202101/13/P2021011300557.htm

HKSARG. (2021c). LCQ18: Medical public-private partnership. https://www.info.gov.hk/gia/
general/202110/20/P2021102000478.htm
HKSARG. (2021d). Summary of expenditure estimates 2021-22.

Hofmarcher, M. M., Oxley, H., & Rusticelli, E. (2007). Improved health system performance
through better care coordination. OECD Papers, 7, 1–85. https://doi.
org/10.1787/246446201766

Honda, A. (2014). What is strategic purchasing for health?
Hong Kong Economic Times. (2020). 疫情令公院服務削減 公私營協作助癌症病人接受治療
由等近一個月加快至最快7日. Topick. https://topick.hket.com/article/2642457/疫情令公院
服務削減 公私營協作助癌症病人接受治療由等近一個月加快至最快7日
Huang, J., Ngai, C.-H., Tin, M.-S., Sun, Q., Tin, P., Yeoh, E.-K., & Wong, M. C. S. (2021).
Healthcare Voucher Scheme for Screening of Cardiovascular Risk Factors: A Population-
Based Study. International Journal of Environmental Research and Public Health, 18(20),
10844. https://doi.org/10.3390/IJERPH182010844
HWB. (2001). Lifelong Investment in Health – Consultation Document on Health Care
Reform.
HWB. (2004). A Study on Health Care Financing and Feasibility of a Medical Savings Scheme
in Hong Kong.
HWFB. (2005). Building a Healthy Tomorrow – Discussion Paper on the Future Service
Delivery Model for Our Health Care System.

IADB. (2011). Chronic Diseases, Primary Care and Health Systems Performance: Diagnostics,
Tools and Interventions.

IMD. (2021). Hong Kong SAR Competitiveness Ranking. IMD World Competitiveness Online.
https://worldcompetitiveness.imd.org/countryprofile/HK/wcy

Jalali, F. S., Bikineh, P., & Delavari, S. (2021). Strategies for reducing out of pocket payments
in the health system: a scoping review. Cost Effectiveness and Resource Allocation, 19(1),
1–22. https://doi.org/10.1186/S12962-021-00301-8

Jiao, F. F., Fung, C. S. C., Wan, E. Y. F., Chan, A. K. C., McGhee, S. M., Kwok, R. L. P., &
Lam, C. L. K. (2018). Five-Year Cost-effectiveness of the Multidisciplinary Risk
Assessment and Management Programme–Diabetes Mellitus (RAMP-DM). Diabetes
Care, 41(2), 250–257. https://doi.org/10.2337/DC17-1149

Jiao, F. F., Fung, C. S. C., Wan, Y. F., McGhee, S. M., Wong, C. K. H., Dai, D. S., Kwok, R., &
Lam, C. L. K. (2015). Long-term effects of the multidisciplinary risk assessment and
management program for patients with diabetes mellitus (RAMP-DM): A population-
based cohort study. Cardiovascular Diabetology, 14(1), 1–11. https://doi.org/10.1186/
s12933-015-0267-3
Jiao, F., Fung, C. S. C., Wan, Y. F., Mcghee, S. M., Wong, C. K. H., Dai, D., Kwok, R., Lam, C.
L. K., Chau, L., & Kong, H. (2016). Effectiveness of the multidisciplinary Risk Assessment
and Management Program for Patients with Diabetes Mellitus (RAMP-DM) for diabetic
microvascular complications: A population-based cohort study. Diabetes & Metabolism,
42, 424–432. https://doi.org/10.1016/j.diabet.2016.07.030

Jiao, F., Wong, C. K. H., Tang, S. C. W., Fung, C. S. C., Tan, K. C. B., McGhee, S., Gangwani,
R., & Lam, C. L. K. (2017). Annual direct medical costs associated with diabetes-related
complications in the event year and in subsequent years in Hong Kong. Diabetic
Medicine, 34(9), 1276–1283. https://doi.org/10.1111/DME.13416

276